相关实验视频

Updated: Jun 11, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

PCSK9单克隆抗体已经走了很长的路

Sandra Zendjebil^1,2,3, Philippe Gabriel Steg^4,5,6

¹Université Paris-Cité, Paris, France.

Current atherosclerosis reports

|October 9, 2024

概括

针对PCSK9的单克隆抗体显著降低了50%的LDL胆固醇,并减少了15-20%的心血管事件. 这些PCSK9单克隆抗体为高风险患者提供了安全有效的选择.

科学领域:

心血管医学心血管医学
药理学药理学是指药理学的学科.
免疫学免疫学免疫学

背景情况:

降脂疗法对于控制心血管疾病至关重要.
PCSK9在调节LDL胆固醇代谢方面发挥着关键作用.
针对PCSK9的单克隆抗体代表了一种新的治疗方法.

研究的目的:

审查PCSK9单克隆抗体在降脂治疗中的作用.
为了强调这些药物的生物和临床影响.

主要方法:

随机对照试验 (RCT) 的审查.
对临床结果和安全数据的分析.
在各种患者群体中评估疗效.

主要成果:

PCSK9单克隆抗体 (Mabs) 将LDL-c降低50%左右.
观察到主要心血管事件的15-20%的相对减少.
在高风险患者中观察到显著的好处,没有严重的不良影响.

结论:

PCSK9 Mabs是有效和安全的降脂剂.
这些疗法对高风险心血管患者具有特别的益处.
由于访问限制,需要更广泛的临床整合.

关键词:

艾利罗库马布 (alirocumab) 是一种药物博科齐祖马布 (Bococizumab) 是一种药物.进化中的黄这包括伊朗.这就是为什么LDL胆固醇是LDL胆固醇.在PCSK9中

更多相关视频

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...